"A simple, affordable, and natural vitamin could be the key to slashing the risk of a second heart attack by half. In a medical breakthrough that challenges the conventional pharmaceutical-focused approach to heart disease, new research demonstrates the profound power of a personalized nutritional strategy. This isn't about a one-size-fits-all pill but about harnessing the body's own needs to foster real healing."
"The findings come from the TARGET-D clinical trial conducted by Intermountain Health in Salt Lake City. Researchers discovered that when patients who had recently suffered a heart attack received vitamin D3 doses tailored to their specific blood levels, they saw their risk of a subsequent heart attack cut by 52 percent. This precise, "target-to-treat" method marks a significant departure from previous failed supplement studies."
"More than half of patients needed a high dose of 5,000 IU daily. The study observed no adverse effects from the tailored treatment. The implications are global, as an estimated half to two-thirds of the world's population has low vitamin D levels. What was once abundantly available through sunlight is now a common deficiency, making targeted supplementation a critical public health conversation."
TARGET-D clinical trial at Intermountain Health in Salt Lake City tailored vitamin D3 doses to achieve specific blood-level targets in patients who recently suffered a heart attack. Patients who received individualized dosing experienced a 52 percent reduction in risk of a subsequent heart attack. More than half of participants required a high dose of 5,000 IU daily to reach target levels. No adverse effects were observed from the tailored treatment. The target-to-treat personalized dosing contrasts with prior trials that used uniform, low doses and found no benefit. Widespread vitamin D insufficiency increases potential public health impact.
Read at Natural Health News
Unable to calculate read time
Collection
[
|
...
]